Characterisation of Phenotypic and Genotypic Antibiotic Resistance Profile of Enterococci from Cheeses in Turkey

Cemil Kürekci*, Sevda Pehlivanlar Önen, Mustafa Yipel1, Özkan Aslantaş2, Aycan Gündoğdu3
Author Information & Copyright
Department of Food Hygiene and Technology, Faculty of Veterinary Medicine, Mustafa Kemal University, Hatay, Turkey
1Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Mustafa Kemal University, Hatay, Turkey
2Department of Microbiology, Faculty of Veterinary Medicine, Mustafa Kemal University, Hatay, Turkey
3Department of Microbiology and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
*Corresponding author: C. Kürekci, Department of Food Hygiene and Technology, Faculty of Veterinary Medicine, Mustafa Kemal University, Hatay, Turkey. Tel: +90-326-221-33-17, Fax:+90-326-245-57-04, E-mail:

Copyright © 2016, Korean Society for Food Science of Animal Resources. This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Dec 07, 2015 ; Revised: Jan 21, 2016 ; Accepted: Apr 07, 2016

Published Online: Jun 30, 2016


The aim of this study was to determine the prevalence of enterococci in cheese samples and to characterize their antimicrobial resistance profiles as well as the associated resistance genes. A total of 139 enterococci were isolated from 99 cheese samples, the isolates were identified as E. faecalis (61.2%), E. faecium (15.1%), E. gallinarum (12.9%), E. durans (5.0%), E. casseliflavis (2.9%) and E. avium (2.9%). The most frequent antimicrobial resistance observed in enterococci isolates was to lincomycin (88.5%), followed by kanamycin (84.2%), gentamycin (low level, 51.1%), rifampin (46.8%) and tetracycline (33.8%). Among the isolates, the frequencies of high level gentamycin and streptomycin resistant enterococci strains were 2.2% and 5.8%, respectively. Apart from the mentioned antibiotics, low levels of resistance to ciprofloxacin, erythromycin and chloramphenicol were found. Moreover no resistance was observed against penicillin and ampicillin. The antimicrobial resistance genes including tetM, tetL, ermB, cat, aph(3’)-IIIa, ant(6)-Ia and aac(6’)-Ieaph(2”)-Ia were found in enterococci from Turkish cheese samples. In the current study, we provided data for antibiotic resistance and the occurrence of resistance genes among enterococci. Regulatory and quality control programs for milk and other dairy products from farms to retail outlets has to be established and strengthened to monitor trends in antimicrobial resistance among emerging food borne pathogens in Turkey.

Keywords: enterococci; cheese; antimicrobial resistance; resistance genes


Enterococci are Gram-positive cocci bacteria that belong to the family enterococcaceae. Enterococci strains are widespread in nature (soil, water and foods) and have been shown to play an important role in contributing to ripening and flavouring processes of certain foods (Foulquie et al., 2006; Franz et al., 1999). In addition to contribution of quality of finished products, some strain of enterococci are believed to be involved in the preservation of foods against food borne pathogens such as Listeria monocytogenes with bacteriocin (Ahmadova et al., 2013). Even though enteroccoci were used to be considered as harmless inhabitants of the gut flora of humans and animals, these organisms are one of the leading causes of nosocomial infections (Leavis et al., 2006). E. feacalis and E. faecium are by far the most prevalent species accounting for over 90% of these infections worldwide (Treitman et al., 2005). Infections associated with enterococci used to be treated successfully with antibiotic treatments, but many antibiotics are currently less effective resulting in longer hospitalization periods, treatment failure and significant financial burdens (DiazGranados et al., 2005). This rapid and global dissemination of multidrug resistant strains were attributed to the imprudent and overuse of antibiotics in human and veterinary practices as well as inappropriate use in animal production (Borgen et al., 2000).

There are a number of well-established international organizations and government agencies such as the Japanese Veterinary Antimicrobial Resistance Monitoring System and DANMAP to monitor antibiotic resistance in order to perform risk assessment for public health (Harada and Asai, 2010). In recent years, efforts have been made to provide some knowledge on the prevalence of enterococci from foods of animal origin, and their antimicrobial resistance worldwide (Hammad et al., 2015; Jamet et al., 2012; Yilmaz et al., 2016). There is evidence supporting the potential transmission of enterococci via the consumption of contaminated foods of animal origin (Olsen et al., 2012). Based on the importance of the emergence of antimicrobial resistant strains of pathogens in foods of animal origins, some studies have examined the prevalence and the frequency of antimicrobial resistance in Enterococci from different retail samples in Turkey (Çitak et al., 2004; Koluman et al., 2009; Özmen Toğay et al., 2005), however no study has been conducted regarding the genetic mechanisms of resistance to aminoglycosides, erythromycin, tetracycline and vancomycin among enterococci isolated from cheese in Turkey. Therefore, the biodiversity of the enterococcal species isolated from eleven different cheeses and their antibiotic resistance profile was determined in this study. In addition, the presence of several antibiotic resistance genes was also screened.

Materials and Methods

Sample collection

In total, one hundred cheese samples were randomly collected from supermarkets, retail markets and open-air markets between January and July 2014 in Hatay, Turkey. The analysed-cheeses consisted of eleven different types of hard, soft and semi-soft ripened cheeses (White, Kasar, Tulum, Ezine, Antep, Sülk, Lor, Van Otlu, Civil, Orgu and Dil) and manufactured in different geographical areas of Turkey. All these cheese samples were collected in sterile bags and transferred in ice-boxes and investigated immediately after arrival at the laboratory.

Isolation and identification of Enterococcus spp.

From each cheese, 25 g of sample was removed and blended for 2 min in a stomacher (BagMixer® 400P, Interscience, France) with 225 mL of buffered peptone water (pH 7.0). Homogenised cheese samples were incubated overnight at 37℃. After that, an aliquot of 100 μL of enriched suspension was added into enterococcal broth and incubated at 37℃ for 24 h. Post-enrichment, 10 μL of this was streaked on the enterococcal agar with and without vancomycin (6 mg/L). From each agar plates, 1-2 suspected colonies with typical enterococci morphology were picked and plated on the blood agar plates. The isolates were identified biochemically by using VITEK2 System (bioMérieux, Marcy-l'Étoile, France).

Antibiotic susceptibility profiles

The susceptibility pattern determination was performed by disk diffusion method on Mueller Hinton agar with antibiotic disks according to the Clinical Laboratory Standards Institute (CLSI, 2012). Fifteen different antibiotics were used: gentamicin (10 μg/disc and 120 μg/disc), streptomycin (300 μg/disc), kanamycin (30 μg/disc), ciprofloxacin (5 μg/disc), vancomycin (30 μg/disc), teicoplanin (30 μg/disc), linezolid (30 μg/disc), lincomycin (10 μg/disc), erythromycin (15 μg/disc), penicillin (10 μg/disc), ampicillin (10 μg/disc), tetracycline (30 μg/disc), chloramphenicol (30 μg/disc), rifampin (5 μg/disc) and quinopristine/dalfopristine (4.5/10.5 μg/disc). E. casseliflavis (ATCC 700327) and Staphylococcus aureus (ATCC 29213) strains were used as positive controls. The results of the antimicrobial susceptibilities were interpreted according to the CLSI guidelines.

Analysis of the molecular mechanisms of antibiotic resistance

Genomic DNA was extracted by using GeneMATRIX bacterial & yeast genomic DNA purification kit (EURx ltd. Gdansk, Poland) according to manufacturer’s instruction. DNA to be analyzed was stored at −20℃. The identification of the genes (ermA, ermB, mefA/E, tetK, tetL, tetM and tetO) that involve in tetracycline and macrolide resistance was performed by a multiplex-PCR approach according to Malhotra-Kumar et al. (2005). All vancomycin resistant, including intermediate resistant, enterococci were screened for resistance genes (vanA, vanB, vanC1/2, vanD, vanE, vanG) by PCR as previously described (Depardieu et al., 2004). The presence of aminoglycosides resistance associated genes (aac(6)-Ie-aph(2)-Ia, aph(2)-Ib, aph(2)-Ic, aph(2)-Id, aph(3)-IIIa, ant(4)-Ia (Vakulenko et al., 2003) and chloramphenicol resistance gene (cat) (Aarestrup et al,. 2000) were also determined by PCR. PCR reactions were carried out with primers stated by abovementioned references.

Results and Discussion

Although the importance of enterococci in food industry as probiotics and starter cultures is unquestioned, they have commonly been implicated in nosocomial infections worldwide (Arias et al., 2010). Having demonstrated that the virulence traits in enterococci strains from food samples were found to be identical to those obtained from humans suggesting that the consumption of animal foods could be a significant source of enterococcal infections (Olsen et al., 2012). Enterococci can tolerate high concentration of salt and contaminate milk and its products easily due to poor hygienic practices at any point of manufacturing. Hence, the incidence and prevalence of enterococci in foods of animal origin have been examined worldwide. Presently, there are some data on the presence of enterococci at the concentration up to 106 CFU/g in cheese samples in Turkey (Aygun et al., 2005; Özmen Toğay et al., 2010). Out of 100 cheese samples, 99 contained enterococci with 61.2% of the isolates identified as E. faecalis, 15.1% as E. faecium, 12.9% as E. gallinarum, 5.0% as E. durans, 2.9% as E. casseliflavis and 2.9% as E. avium in the current study.

In Turkey, the prevalence of enterococci in cheese samples was reported to range between 60 and 100% according to the prior studies (Çitak et al., 2004; Koluman et al., 2009; Özmen Toğay et al., 2010). The most recently observed prevalence of enterococci in dairy products in other countries include 100% in Brazil (Furlaneto-Maia et al., 2014), 90% in Egypt (Hammad et al., 2015), 72% in France (Jamet et al., 2012) and 27% in Italy (Pesavento, 2014). The prevalence and species distribution of enterococci in foods of animal origin varies by country and type of foods. It was also previously shown that known factors in manufacturing process such as pasteurization of milk can influence the abundance and prevalence of enterococci in the final products (Jamet et al., 2012). In this study, E. faecalis was found to be the most frequently isolated species which is in accordance to data published in European countries and in Turkey (Jamet et al., 2012; Koluman et al., 2009; Nieto-Arribas et al., 2011; Özmen Toğay et al., 2010). In contrast, there are also some studies reporting E. faecium being the most frequently isolated species (Hammad et al., 2015; Tuncer, 2009).

Enterococci are noted for their intrinsic resistance to aminoglycoside (low level) and β-lactam antibiotics. The high level resistance to gentamicin and streptomycin is of significant importance because of their use in the treatment of enterococcal infections (Arias et al., 2010) and characterised by no growth zone around the discs (120 μg for gentamycin and 300 μg for streptomycin) (CLSI, 2012). In the current study, 84.2% (117/139) of enterococci isolates were found to be resistant to kanamycin, 5.8% (8/139) to high level streptomycin and 51.1% (71/139) to gentamycin, whereas high level gentamycin resistance was found in three (2.2%) isolates (two E. faecalis, and one E. gallinarum) (Table 1). The multiplex-PCR analysis showed that two E. feacalis isolates harbor the aph(3)-IIIa gene and a single E. gallinarum isolate had the acc6-leaph(2)-la gene (Table 2). Recently, we detected the aph (3’)-IIIa, ant(6)-Ia and aac(6’)-Ie-aph(2”)-Ia genes in E. feacalis isolates obtained from chicken meat (Yilmaz et al., 2016). Our results are higher than those recently noted in Egypt where only one E. faecium strain with aph (3) gene was recorded (Hammad et al., 2015). A recent study from France reported that only 7% of raw cheese samples were contaminated with low level gentamycin of which three strains had the aph2-aac6 gene (Jamet et al., 2012). In addition, there was no high level gentamycin enterococci found in Spanish cheeses (Nieto-Arribas et al., 2011). The occurrence of high level resistance to gentamicin has previously reported among enterococci isolates from clinical infections (Araoka et al., 2011; Dorabat et al., 2010), animals (Choi and Woo, 2013; Liu et al., 2012) and foods of animal origins (Hammad et al., 2014; Hammad et al., 2015). However, to our best knowledge, this study revealed the presence of E. feacalis and E. gallinarum with aminoglycoside resistance genes from cheeses in Turkey for the first time.

Table 1. Antimicrobial susceptibilities of Enterococci isolates from cheeses in Turkey
Antibiotics1 Number (%) of resistant strains
Total (n=139)
E. faecalis (n=85) E. faecium (n=21) E. gallinarum (n=18) E. casseliflavis (n=4) E. durans (n=7) E. avium (n=4)
TEC 9 (10.6) 0 0 0 0 0 9 (6.5)
VA 3 (3.5) 0 0 0 0 0 3 (2.2)
CN (120 μg) 2 (2.4) 0 1 (5.6) 0 0 0 3 (2.2)
CN (10 μg) 61 (71.8) 7 (33.3) 2 (11.1) 0 0 1 (25.0) 71 (51.1)
K 67 (78.8) 21 (100.0) 17 (94.4) 4 (100.0) 7 (100.0) 1 (25.0) 117 (84.2)
RD 46 (54.1) 14 (66.7) 3 (16.7) 1 (25.0) 1 (14.3) 0 65 (46.8)
TE 40 (47.1) 0 5 (27.8) 1 (25.0) 0 1 (25.0) 47 (33.8)
E 8 (9.4) 7 (33.3) 1 (5.6) 0 0 0 16 (11.5)
MY 84 (98.8) 10 (47.6) 18 (100.0) 4 (100.0) 3 (42.9) 4 (100.0) 123 (88.5)
P 0 0 0 0 0 0 0/0
AMP 0 0 0 0 0 0 0/0
LZD 6 (7.1) 0 2 (11.1) 0 0 0 8 (5.8)
QD 55 (64.7) 1 (4.8) 2 (11.1) 0 0 1 (25.0) 59 (42.4)
C 4 (4.7) 0 0 0 0 1 (25.0) 5 (3.6)
S 7 (8.2) 0 1 (5.6) 0 0 0 8 (5.8)
CIP 0 3 (14.3) 1 (5.6) 0 0 0 4 (2.9)

1TEC, teicoplanin; VA, vancomycin; CN, gentamicin; K, kanamycin; RD, rifampin; TE, tetracycline; E, erithromycin; MY, lincomycin; P, penicillin; AMP, ampicillin; LZD, linezolid; QD, quinopristine/dalfopristine; C, chloramphenicol; S, streptomycin; CIP, ciprofloxacin.

Download Excel Table
Table 2. The genotypic and phenotypic characteristics of Enterococcus spp. that harboured resistance genes
Species Antibiotic resistance phenotype Antibiotic Resistance Genes
E. faecalis K, TE, E, MY, QD tetM, ermB
E. faecalis CN K, TE, MY tetM
E. faecalis CN, K, TE, MY, QD tetM
E. faecalis CN, K, TE, MY, QD, S tetM
E. faecalis CN, K, TE, E, MY, QD, C, S tetM, ermB, cad
E. faecalis CN, K, TE, MY tetM
E. faecalis CN, K, RD, TE, MY tetM
E. faecalis CN, K, RD, TE, MY, QD tetM
E. faecalis K, TE, MY, tetM
E. faecalis CN, K, RD, TE, MY tetM
E. faecalis CN, TE, MY, tetM
E. faecalis CN, K, RD, TE, MY tetM
E. faecalis CN, K, RD, MY tetM
E. faecalis TE, MY, QD tetM
E. faecalis TE, MY tetM
E. faecalis RD, TE, MY, QD tetM
E. faecalis CN, K, TE, E, MY, QD, C, S tetM, tetL, ermB, cat
E. faecalis CN, CN (120), K, RD, TE, E, MY, QD, S tetM, tetL, cat, aph(3)IIIa
E. faecalis K, RD, TE, MY, tetM
E. faecalis CN, K, RD, TE, MY tetM
E. faecalis RD, TE, MY tetM
E. faecalis TE, MY tetM
E. faecalis K, TE, MY, S tetM
E. faecalis TE, MY, QD tetM
E. faecalis CN, K, TE, MY, QD tetM
E. faecalis CN, CN (120), K, MY, QD acc6-le-aph(2)-la
E. faecalis CN, K, TE, E, MY, QD, C, S tetM, ermB, cat
E. faecalis CN, K, RD, TE, E, MY, QD, C, S tetM, ermB, cat
E. faecalis CN, K, RD, TE, MY, QD tetM
E. faecalis TEC, CN, K, RD, TE, MY, QD tetM
E. faecalis CN, K, RD, TE, MY, LZD, QD tetM
E. faecalis TEC, CN, K, RD, TE, MY tetM
E. faecalis CN, K, RD, TE, MY tetM
E. faecalis CN, K, RD, TE, MY tetM
E. faecalis CN, K, RD, TE, MY, QD tetM
E. faecalis K, RD, E, MY tetL
E. gallinarum CN, CN (120), K, TE, E, MY, LZD, QD, S, CIP tetM, ermB, aph(3)-IIIa
E. avium CN, K, TE, MY, QD, C tetM
E. casseliflavis K, TE, MY tetM

VA, vancomycin; CN, gentamicin; K, kanamycin; RD, rifampin; TE, tetracycline; E, erithromycin; MY, lincomycin; LZD, linezolid; QD, quinopristine/dalfopristine; C, chloramphenicol; S, streptomycin; CIP, ciprofloxacin.

Download Excel Table

The glycopeptide group of antibacterial agents (vancomycin and teicoplanin) are recognised as very reliable reserve antibiotics against multi-drug resistance enterococci in humans (Kos et al., 2012). In 1988, vancomycin resistant enterococci (VRE) was first reported in European countries (Leclercq et al., 1988; Uttley et al., 1988), and since then VRE have been frequently isolated worldwide. From a total of 100 cheese samples, only five (5%) samples were found to be contaminated with VRE in this study (Table 1). Of the five VRE isolates, three (3.5%) were found to have full resistance while other two were with intermediate resistance. In 2004, a study carried out by Çitak et al. (2004) revealed a high frequency of vancomycin resistance among E. feacalis and E. faecium from Turkish white cheese as high as 96.8% and 76% respectively. However, a more recent report revealed lower levels (13.1%) of intermediate vancomycin resistance among enterococci isolated from fermented foods including cheese in Turkey (Özmen Toğay et al., 2010). Recently, studies reported vancomycin resistance rates among enterococci from dairy products in Europe ranging between none in France (Jamet et al., 2012), and 2% in Spain (Nieto- Arribas et al., 2011). There have been nine types of glycopeptide resistance (vanA, vanB, vanC, vanD, vanE, vanG, vanI, vanM and vanN) characterized and reported in enterococci so far. Despite recent study in which the vanA gene was shown to be present in 7% of enterococci obtained from chicken meat in Turkey (Yilmaz et al., 2016), we did not find any glycopeptide resistance genes tested. Similarly, in Egypt, 5% of enterococci isolates from Egyptian raw Karish cheeses were found to be vancomycin resistant but vancomycin resistant genes were not detected in these isolates (Hammad et al., 2015). The results of this study also demonstrate that VRE has decreased dramatically from over 70% in 2004 (Çitak et al., 2004) to 5% in the current study. Because widespread use of avoparcin as a growth promoting agent in animal production led to emergence of vancomycin-resistant enterococci in humans, animal and animal products, this dramatic decrease might be attributed to the ban of antibiotic usage in animal production starting from 2006. When the use of avoparcin in animal production was banned in 1996, the prevalence of VRE decreased markedly in European countries (Borgen et al., 2000; Bortolaia et al., 2015).

Resistance to other class of antibiotics including erythromycin and tetracycline among enterococci obtained from foods of animal origin has been previously described as a common trait (Hammad et al., 2015; Jamet et al., 2012; Koluman et al., 2009; Nieto-Arribas et al., 2011). In our study, the highest resistance was observed for lincomycin (88.5%) (Table 1), which is not surprising as most enterococci were reported to have intrinsic resistance to lincosamides (Klare et al., 2003). About 11.5-34% of the enterococcal isolates were also resistant to tetracycline and erythromycin, respectively. A low level resistance to ciprofloxacin (2.9%) and resistance to chloramphenicol (3.6%) was noticed in this study. Yet, all enterococci strains were sensitive to ampicillin and penicillin. Antibiotic resistance profile we observed in this study was in accordance with those reported for the fermented Turkish foods and chicken meats in turkey (Özmen Toğay et al., 2010; Yilmaz et al., 2015) and cheeses in Europe (Jamet et al., 2012; Nieto-Arribas et al., 2011) and in Egypt (Hammad et al., 2015). The high frequency of resistance to tetracycline among enterococci isolated from animal foods has previously been attributed to its extensive usage in veterinary practice (Hammad et al., 2015). In contrast to our findings, Çitak et al. (2004) reported higher levels of resistance among enterococci isolated from Turkish white cheese sample, which may be related to the ban of antibiotic usage in animal production as a growth promoter in 2006. This study found that E. feacalis strains were more resistant to antibiotics compared to other species. In a study carried out in Italy, E. feacalis strains were found to be resistant to antibiotics more frequently than other species (Pesavento et al., 2014). In addition, the strains of E. durans were found to be less antibiotic resistant when compared to other species, which is not surprising as E. durans has long been generally used as starter cultures in dairy technology (Litopoulou-Tzanetaki et al., 1993; Pesavento et al., 2014). The gene encoding 23S rRNA methylases, ermB, was found in five E. faecalis strains and in a single E. gallinarum strains (Table 2). Of the six tetracycline resistant genes, tetM was present in 26.6% (37/139) of the isolates, followed by tetL gene that was present in only 2.2% (3/139) (Table 2). We recently observed tetM as the most predominant gene in tetracycline resistant enterococci found in raw minced meat in Turkey (Yilmaz et al., 2015). The five chloramphenicol resistance E. feacalis strains (one having intermediate resistance) had cat gene, but this gene was not present in E. avium strain that was also resistant to choloramphenicol (Table 2). The presence and particular involvement of tetM, tetL, ermB and cat genes for resistance phenotypes has already been presented in enterococci isolated from foods of animal origin including cheese around the world (Hammad et al., 2014; Jamet et al., 2012; Nieto-Arribas et al., 2011).

Some antibiotics (quinopristine/dalfopristine, rifampin and linezolid) examined in this study are critically important classes of antibiotics for the treatment of VRE infections evaluated by WHO (2011) and there is no data available for their usage in veterinary medicine in Turkey. In this study, 46.8% of the isolates were found to be resistant to rifampin and 42.4% were resistant to quinopristine/dalfopristine with E. feacalis (64.7%; 55/85) showing higher resistance than E. avium (25%; 1/4), E. gallinarum (11.1%; 2/18) and E. faecium (4.8%; 1/21) (Table 1). We found that 5.8% of isolates were resistant to linezolid (six E. faecalis and two E. gallinarum). Quinopristine/dalfopristine is one of the approved antibiotics for the treatment of vancomycin resistant E. faecium infections (Liu et al., 2012) which necessitates the regular monitoring of resistance against these classes of antibiotics among the isolates obtained from foods of animal origin.

As a result, this study does not produce enough evidence to rule out that cheese samples are a definitive vehicle of infection in humans. However, the occurrence of multidrug resistant enterococci in cheese samples highlights a potential source for humans. It seems noteworthy that the presence of antibiotic resistant enterococci in cheese possesses a health risk since vancomycin resistant infections are highly associated with VRE colonization in humans (Kim et al., 2012). In addition, the presence of antibiotic resistance genes detected in enterococci indicates a risk factor for dissemination of genes through food. Taking abovementioned results into consideration, some elementary hygiene principles with together quality management in dairy plants have to be applied urgently in order to reduce the frequency of multidrug resistant strains of enterococci in Turkey.


We thank Dr. Rafat Al Jassim (The University of Queensland) for his valuable comments on the manuscript.



Aarestrup F. M., Agrees Y., Gerner-Smith P., Madsen M., Jensen L. B. Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers and pigs in Denmark. Diagn. Micr. Infec. Dis. 2000; 37:127-137.


Ahmadova A., Todorov S. D., Choiset Y., Rabesona H., Zadi T. M., Kuliyev A., Melo Franco B. D. G., Chobert J. M., Thomas Haertlé T. Evaluation of antimicrobial activity, probiotic properties and safety of wild strain Enterococcus faecium AQ71 isolated from Azerbaijani Motal cheese. Food Control. 2013; 30:631-641.


Araoka H., Kimura M., Yoneyama A. A surveillance of high-level gentamicin-resistant enterococcal bacteremia. J. Infect. Chemother. 2011; 17:433-434.


Arias C. A., Contreras G. A., Murray B. E. Management of multidrug-resistant enterococcal infections. Clin. Microbiol. Infec. 2010; 16:555-562.


Aygun A., Aslantas O., Oner O. A survey on the microbiological quality of Carra, a traditional Turkish cheese. J. Food Eng. 2005; 66:401-404.


Borgen K., Simonsen G. S., Sundsfjord A., Wasteson Y., Olsvik E., Kruse H. Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned. J. Appl. Microbiol. 2000; 89:478-485.


Bortolaia V., Mander M., Jensen L. B., Olsen J. E., Guardabassi L. Persistance of vancomycin resistance in multiple clones of Enterococcus faecium isolated from Danish broilers 15 years after the ban of avoparcin. Antimicrob. Agents Chemother. 2015; 59:2926-2929.


Choi J. M., Woo G. J. Molecular characterization of high-level gentamicin-resistant Enterococcus faecalis from chicken meat in Korea. Int. J. Food Microbiol. 2013; 165:1-6.


Çitak S., Yucel N., Orhan S. Antibiotic resistance and incidence of Enterococcus species in Turkish white cheese. Int. J. Dairy Technol. 2004; 57:27-31.


Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-second informational supplement. CLSI document, M100-S22, 32, 3. 2012Retrieved August 05, 2015, from


Depardieu F., Perichon B., Courvalin P. Detection of the van alphabet and identification of Enterococci and Staphylococci at the species level by multiplex PCR. J. Clin. Microbiol. 2004; 42:5857-5860.


DiazGranados C. A., Zimmer S. M., Mitchel K., Jernigan J. A. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis. Clin. Infect. Dis. 2005; 41:327-333.


Foulquie M. M. R., Sarantinopoulos P., Tsakalidou E., DeVuyst L. The role and application of enterococci in food and health. Int. J. Food Microbiol. 2006; 106:1-24.


Franz C. M. A. P., Holzapfel W. H., Stiles M. E. Enterococci at the crossroads of food safety. Int. J. Food Microbiol. 1999; 47:1-24.


Furlaneto-Maia L., Rocha K. R., Henrique F. C., Giazzi A., Furlaneto M. C. Antimicrobial resistance in Enterococcus sp. isolated from soft cheese in southern Brazil. Adv. Microbiol. 2014; 4:175-181.


Hammad A. M., Hassan H. A., Shimamoto T. Prevalence, antibiotic resistance and virulence of Enterococcus spp. in Egyptian fresh raw milk cheese. Food Control. 2015; 50:815-820.


Hammad A. M., Shimamoto T., Shimamoto T. Genetic characterization of antibiotic resistance and virulence factors in Enterococcus spp. from Japanese retail ready-toeat raw fish. Food Microbiol. 2014; 38:62-66.


Harada K., Asai T. Role of antimicrobial selective pressure and secondary factors on antimicrobial resistance prevalence in Escherichia coli from food-producing animals in Japan. J. Biomed. Biotechnol. 2010 2010.


Jamet E., Akary E., Poisson M. A., Chamba J. F., Bertrand X., Serror P. Prevalence and characterization of antibiotic resistant Enterococcus faecalis in French cheeses. Food Microbiol. 2012; 31:191-198.


Kim Y. J., Kim S. I., Kim Y. R., Lee J. Y., Park Y. J., Kang M. W. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission. Am. J. Infect. Control. 2012; 40:1018-1019.


Klare I., Konstabel C., Badstübner D., Werner G., Witte W. Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int. J. Food Microbiol. 2003; 88:269-290.


Koluman A., Akan L. S., Çakiroglu F. P. Occurrence and antimicrobial resistance of enterococci in retail foods. Food Control. 2009; 20:281-283.


Kos V. N., Desjardins C. A., Griggs A., Cerqueira G., van Tonder A., Holden M. T. G., Godfrey P., Palmer K. L., Bodi K., Mongodin E. F., Wortman J., Feldgarden M., Lawley T., Gill S. R., Haas B. J., Birren B., Gilmore M. S. Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with methicillin-resistant S. aureus hospital-acquired infection in the United States. mBio. 2012; 3:e00112-12.


Leavis H. L., Bonten M. J., Willems R. J. Identification of high-risk enterococcal clonal complexes: Global dispersion and antibiotic resistance. Curr. Opin. Microbiol. 2006; 9:454-460.


Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. New Engl. J. Med. 1988; 319:157-161.


Litopoulou-Tzanetaki E., Tzanetakis N., Vafopoulou Mastrojannaki A. Effect of type of lactic starter on microbiological, chemical and sensory characteristics of feta cheese. Food Microbiol. 1993; 10:31-41.


Liu Y., Liu K., Lai J., Wu C., Shen J., Wang Y. Prevalence and antimicrobial resistance of Enterococcus species of food animal origin from Beijing and Shandong province, China. J. Appl. Microbiol. 2012; 114:555-563.


Malhotra-Kumar S., Lammens C., Piessens J., Goossens H. Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci. Antimicrob. Agents Chemother. 2005; 49:4798-4800.


Nieto-Arribas P., Seseña S., Poveda J. M., Chicón R., Cabezas L., Palop L. Enterococcus populations in artisanal Manchego cheese: Biodiversity, technological and safety aspects. Food Microbiol. 2011; 28:891-899.


Olsen R. H., Schønheyder H. C., Christensen H., Bisgaard M. Enterococcus faecalis of human and poultry origin share virulence genes supporting the zoonotic potential of E. faecalis. Zoonoses Public Hlth. 2012; 59:256-263.


Özmen Toğay S., Çelebi Keskin A., Açik L., Temiz A. Virulence genes, antibiotic resistance and plasmid profiles of Enterococcus faecalis and Enterococcus faecium from naturally fermented Turkish foods. J. Appl. Microbiol. 2010; 109:1084-1092.


Pesavento G., Calonico C., Ducci B., Magnanini A., Lo Nostro A. Prevalence and antibiotic resistance of Enterococcus spp. isolated from retail cheese, ready-to-eat salads, ham, and raw meat. Food Microbiol. 2014; 41:1-7.


Treitman A. N., Yarnold P. R., Warren J., Noskin G. A. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J. Clin. Microbiol. 2005; 43:462-463.


Tuncer Y. Some technological properties of phenotypically identified enterococci strains isolated from Turkish tulum cheese. Afr. J. Biotechnol. 2009; 8:7008-7016.


Uttley A. H., Collins C. H., Naidoo J., George R. C. Vancomycin-resistant enterococci. Lancet. 1988; 1:57-58.


Vakulenko S. B., Zervos M. J., Donabedian S. M., Lerner S. A., Voskresenskiy A. M., Chow J.W. Multiplex PCR for detection of aminoglycoside resistance genes in enterococci. Antimicrob. Agents Chemother. 2003; 47:1423-1426.


World Health Organization (WHO) Critically Important Antimicrobials for Human Medicine, third revision. WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR). WHO Press. Geneva, Switzerland: 2011.


Yilmaz E. S., Aslantas Ö., Pehlivanlar Önen S., Türkyilmaz S., Kürekci C. Prevalence, antimicrobial resistance and virulence traits in enterococci from food of animal origin in Turkey. LTW-Food Sci. Technol. 2016; 66:20-26.

FSAR Special Section Invitation

We are pleased to invite you to submit special section paper for Food Science and Animal Resources (FSAR). Both full-length research articles and review articles are welcome for the following issues.

 - Benefits: All the accepted papers for the special topics are eligible for the 50% article processing charge (APC) discount.
 - Deadline for manuscript submissions: 31 May 2023

The topics of interest for the special issue include:
 ■ Innovative strategies to improve the quality of animal-based products
  (Editor: Dr. Young Min Choi)
  - Application of proteomics and lipidomics in quality of meat and milk products
  - Functional ingredients and additives for structure formation
  - Meal kits and home meal replacement (HMR), Etc.

 ■ Innovative safety and freshness control of animal-based products
 (Editor: Dr. Changsun Choi)
  - High pressure processing
  - Plasma technology
  - Advanced active packaging and sensor technology (quality indicator, time-and temperature indicator, etc)
  - Edible coating, etc.

I don't want to open this window for a day.